{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Bone Biologics Corp"},"Symbol":{"label":"Symbol","value":"BBLGW"},"Address":{"label":"Address","value":"United States"},"Phone":{"label":"Phone","value":""},"Industry":{"label":"Industry","value":"Industrial Specialties"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has application in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine."},"CompanyUrl":{"label":"Company Url","value":"https://www.bonebiologics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jeffrey Frelick","title":"President & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}